MedTrace Logo

TRACK-TBI Longitudinal Biomarker Study

NCT05201833 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-07-16

No results posted yet for this study

Summary

The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.

Conditions

Interventions

BEHAVIORAL

Telephone Outcome Assessment

Assessments will be administered over the telephone to evaluate participant outcome status

BEHAVIORAL

In-Person Outcome Assessment

Assessments will be administered to evaluate participant outcome status

PROCEDURE

3T Magnetic Resonance Imaging (MRI)

Participants will be asked to complete a 3T MRI

PROCEDURE

Blood Draw

Blood Draw for Plasma, DNA, Serum, RNA

Sponsors & Collaborators

  • National Football League

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Ramon Diaz-Arrastia, MD, PhD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2026-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05201833 on ClinicalTrials.gov